EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Effectiveness of an Impella Versus Intra‐Aortic Balloon Pump in Patients Who Received Extracorporeal Membrane Oxygenation

Yuji Nishimoto iD, Hiroyuki Ohbe iD, Jun Nakata, Toru Takiguchi iD, Mikio Nakajima iD, Yusuke Sasabuchi, Toshiaki Isogai iD, Hiroki Matsui iD, Yukihito Sato iD, Tetsuya Watanabe iD, Takahisa Yamada iD, Masatake Fukunami iD und 1 weitere

Journal of the American Heart Association · 04.02.2025 · 14 (3)

DOI: 10.1161/jaha.124.037652 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 04.02.2025. Verfasst von Yuji Nishimoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology Osaka General Medical Center Osaka Japan. Hauptthemen laut MEDLINE: Intra-Aortic Balloon Pumping, Extracorporeal Membrane Oxygenation, Heart-Assist Devices, Shock, Cardiogenic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is unclear whether an intra‐aortic balloon pump (IABP) or percutaneous ventricular assist device (Impella) in combination with extracorporeal membrane oxygenation (ECMO) is better.

Methods

Using the Japanese Diagnosis Procedure Combination database from September 2016 to March 2022, we identified inpatients who received an Impella or IABP in combination with ECMO (ECPella or ECMO+IABP group, respectively). The primary outcome was in‐hospital mortality, and the secondary outcomes included the length of hospital stay, length of ECMO, total hospitalization cost, complications, and durable mechanical circulatory support implantations. Propensity score matching was performed to compare the outcomes between the groups.

Results

Of 14 319 eligible patients, 590 (4.1%) received ECPella and 13 729 (96%) received ECMO+IABP. The mean age of patients was 65 years, 77% were men, and 57% had acute coronary syndrome. After propensity score matching, the patient characteristics were well balanced between the groups. The 14‐day mortality rate was lower in the ECPella group than in the ECMO+IABP group (28.0% versus 36.8%; risk difference, −8.2% [95% CI, −13.8 to −2.7]), whereas there was no significant difference in in‐hospital mortality between the groups (58.3% versus 56.6%; risk difference, 2.4% [95% CI, −3.5 to 8.2]). The ECPella group had a higher total hospitalization cost, increased renal replacement therapy during hospitalization, and more durable mechanical circulatory support implantations than the ECMO+IABP group.

Conclusions

This nationwide inpatient database study showed no significant difference in in‐hospital mortality between the groups, but ECPella was associated with a higher total hospitalization cost, increased renal replacement therapy during hospitalization, and more durable mechanical circulatory support implantations than ECMO+IABP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intra-Aortic Balloon PumpingExtracorporeal Membrane OxygenationHeart-Assist DevicesShock, CardiogenicHumansMaleFemaleAgedHospital MortalityMiddle AgedRetrospective StudiesJapanTreatment OutcomePropensity ScoreLength of StayDatabases, FactualHospital Costs

Stichwörter der Autor:innen

cardiogenic shockextracorporeal membrane oxygenationheart assist deviceintra‐aortic balloon pumpmechanical circulatory support

Autor:innen und Institutionen

  • Division of Cardiology Osaka General Medical Center Osaka Japan.
  • Department of Clinical Epidemiology and Health Economics, School of Public Health The University of Tokyo Japan.
  • Division of Cardiovascular Intensive Care Nippon Medical School Tokyo Japan.
  • Department of Emergency and Critical Care Medicine Nippon Medical School Tokyo Japan.
  • Emergency and Critical Care Center Tokyo Metropolitan Hiroo Hospital Tokyo Japan.
  • Department of Real-world Evidence, Graduate School of Medicine The University of Tokyo Japan.

ORCID-Profile: Yuji Nishimoto, Hiroyuki Ohbe, Toru Takiguchi, Mikio Nakajima, Toshiaki Isogai, Hiroki Matsui, Yukihito Sato, Tetsuya Watanabe, Takahisa Yamada, Masatake Fukunami, Hideo Yasunaga

Zitieren

APA

Nishimoto, Y., Ohbe, H., Nakata, J., Takiguchi, T., Nakajima, M., Sasabuchi, Y., Isogai, T., Matsui, H., Sato, Y., Watanabe, T., Yamada, T., Fukunami, M., & Yasunaga, H. (2025). Effectiveness of an Impella Versus Intra‐Aortic Balloon Pump in Patients Who Received Extracorporeal Membrane Oxygenation. Journal of the American Heart Association, 14(3). https://doi.org/10.1161/jaha.124.037652

Vancouver

Nishimoto Y, Ohbe H, Nakata J, Takiguchi T, Nakajima M, Sasabuchi Y, et al. Effectiveness of an Impella Versus Intra‐Aortic Balloon Pump in Patients Who Received Extracorporeal Membrane Oxygenation. Journal of the American Heart Association. 2025;14(3). doi:10.1161/jaha.124.037652

BibTeX
@article{Nishimoto2025,
  author = {Nishimoto, Yuji and Ohbe, Hiroyuki and Nakata, Jun and Takiguchi, Toru and Nakajima, Mikio and Sasabuchi, Yusuke and Isogai, Toshiaki and Matsui, Hiroki and Sato, Yukihito and Watanabe, Tetsuya and Yamada, Takahisa and Fukunami, Masatake and Yasunaga, Hideo},
  title = {Effectiveness of an Impella Versus Intra‐Aortic Balloon Pump in Patients Who Received Extracorporeal Membrane Oxygenation},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {3},
  doi = {10.1161/jaha.124.037652}
}
Kostenlos starten →